Abstract
The COVID-19 pandemic has led to the admission of a high number of patients to the ICU, generally due to severe respiratory failure. Since the appearance of the first cases of SARS-CoV-2 infection, at the end of 2019, in China, a huge number of treatment recommendations for this entity have been published, not always supported by sufficient scientific evidence or with methodological rigor necessary. Thanks to the efforts of different groups of researchers, we currently have the results of clinical trials, and other types of studies, of higher quality. We consider it necessary to create a document that includes recommendations that collect this evidence regarding the diagnosis and treatment of COVID-19, but also aspects that other guidelines have not considered and that we consider essential in the management of critical patients with COVID-19. For this, a drafting committee has been created, made up of members of the SEMICYUC Working Groups more directly related to different specific aspects of the management of these patients.
【저자키워드】 COVID-19, SARS-CoV-2, Critical care, COVID-19 drug treatment, intensive care units, COVID-19 testing, 【초록키워드】 Treatment, SARS-COV-2 infection, COVID-19 pandemic, severe respiratory failure, Diagnosis, clinical trials, ICU, China, management, Patient, group, Admission, Critical, patients, Evidence, effort, working, recommendation, researchers, include, supported, methodological, patients with COVID-19, 【제목키워드】 intensive care unit, management, Critically ill patient, with COVID-19,